RYR2 and catecholaminergic polymorphic ventricular tachycardia: Alternatively, siRNA delivery to silence mutant mRNA of RyR2 in an allele-specific manner or genome-editing approach has proven effective in normalizing cardiac electrophysiology in a mouse model of CPVT [52].